- INCREASE (inhaled treprostinil)
-
Product
INCREASE
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase 3INCREASE - Phase 3 clinical trial with Tyvaso® (treprostinil) Inhalation Solution for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD).
LEARN MORE Close - Tyvaso DPI™ (inhaled treprostinil)
-
Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 1 (PAH)Pulmonary Hypertension (PH) WHO Group 3Status
Phase 3Dry Powder Inhaled (DPI) treprostinil in a small handheld device for the treatments of pulmonary arterial hypertension (PAH), and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
LEARN MORE Close - PERFECT (inhaled treprostinil)
-
Product
PERFECT
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase 3Phase 3 clinical trial with Tyvaso® (treprostinil) Inhalation Solution for the treatment of pulmonary hypertension due to chronic obstructive pulmonary disease (PH-COPD).
LEARN MORE Close - TETON (inhaled treprostinil)
-
Product
TETON
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Chronic Fibrosing Interstitial Lung DiseaseStatus
Phase 3A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Patients with Chronic Fibrosing Interstitial Lung Disease.
LEARN MORE Close
Menu